Works matching IS 10834389 AND DT 2024 AND VI 29 AND IP 2

Results: 21

Four cases of non‐Helicobacter pylori Helicobacter‐infected gastritis with duodenal spiral bacilli.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13083

By:

Agawa, Hiroyuki;
Tsukadaira, Toshihisa;
Kobayashi, Natsuko;
Kodaira, Himiko;
Ota, Hiroyoshi;
Matsumoto, Takehisa;
Horiuchi, Kazuki;
Negishi, Tatsuya;
Tada, Toshifumi

Publication type:

Article

Prevalence of Helicobacter pylori infection among Slovenian children and adolescents: A prospective cohort study.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13082

By:

Šterbenc, Anja;
Godnov, Uroš;
Vodičar, Polona Maver;
Simčič, Saša;
Jeverica, Samo;
Zaletel, Živa;
Homan, Pia;
Mojškerc, Eva Miler;
Homan, Matjaž

Publication type:

Article

Diagnostic performance of linked color imaging for gastric cancer by Helicobacter pylori infection status: A subanalysis of the large‐scale, multicenter randomized controlled trial LCI‐FIND.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13080

By:

Kato, Mototsugu;
Ono, Shoko;
Kawada, Kenro;
Dohi, Osamu;
Kitamura, Shinji;
Koike, Tomoyuki;
Hori, Shinichiro;
Kanzaki, Hiromitsu;
Murao, Takahisa;
Yagi, Nobuaki;
Sasaki, Fumisato;
Hashiguchi, Keiichi;
Oka, Shiro;
Katada, Kazuhiro;
Shimoda, Ryo;
Mizukami, Kazuhiro;
Suehiro, Mitsuhiko;
Takeuchi, Toshihisa;
Katsuki, Shinichi;
Tsuda, Momoko

Publication type:

Article

Dynamic changes in the gut microbiota after bismuth quadruple therapy and high‐dose dual therapy for Helicobacter pylori eradication.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13077

By:

Chen, Jing;
Zhang, Yan;
Min, Hanchen;
Zhi, Junli;
Ma, Shuyun;
Dong, Hongxia;
Yan, Jingshuang;
Chi, Xiaoyan;
Zhang, Xiaomei;
Yang, Yunsheng

Publication type:

Article

14‐day tailored PCR‐guided triple therapy versus 14‐day non‐Bismuth concomitant quadruple therapy for Helicobacter pylori eradication: A multicenter, open‐label randomized noninferiority controlled trial.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13076

By:

Amiot, Aurelien;
Hacoon, Jérémy;
Heluwaert, Frederic;
Mion, François;
Lamarque, Dominique;
Moussata, Driffa;
Mimouni, Maroua;
Delchier, Jean‐Charles;
Durand‐Zaleski, Isabelle;
Audureau, Etienne;
Bastuji‐Garin, Sylvie;
Kedzia, Cecile;
Samia, Baloul;
Dalila, Selmane;
Amel, Gouja;
Petitdidier, Nicolas;
Gagniere, Charlotte;
Martin, Antoine;
Levy, Michael;
Nebbad, Biba

Publication type:

Article

Evaluating the potency of zoliflodacin against Helicobacter pylori: In vitro activity and conserved GyrB target.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13075

By:

Liu, Jing;
Jia, Jia;
Shi, Ting;
Bai, Yuefan;
Huang, Yanqiang;
Zeng, Liping;
Bi, Hongkai

Publication type:

Article

A reconstructed genome‐scale metabolic model of Helicobacter pylori for predicting putative drug targets in clarithromycin and rifampicin resistance conditions.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13074

By:

Mofidifar, Sepideh;
Yadegar, Abbas;
Karimi‐Jafari, Mohammad Hossein

Publication type:

Article

Application of cefuroxime in the eradication therapy of Helicobacter pylori infection: A review article.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13073

By:

Mi, Changmin;
Suo, Baojun;
Tian, Xueli;
Wang, Yuxin;
Ma, Lingling;
Song, Zhiqiang

Publication type:

Article

Helicobacter pylori with trx1 high expression promotes gastric diseases via upregulating the IL23A/NF‐κB/IL8 pathway.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13072

By:

Guan, Xin;
Ning, Jing;
Fu, Weiwei;
Wang, Ye;
Zhang, Jing;
Ding, Shigang

Publication type:

Article

The role of microbiota in gastric cancer: A comprehensive review.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13071

By:

Lei, Changzhen;
Xu, Yitian;
Zhang, Shaopeng;
Huang, Chen;
Qin, Jing

Publication type:

Article

Diagnosis by combination of endoscopic findings helps differentiate non‐Helicobacter pylori Helicobacter‐infected gastritis from Helicobacter pylori‐infected gastritis.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13070

By:

Okamura, Takuma;
Iwaya, Yugo;
Nagaya, Tadanobu;
Horiuchi, Kazuki;
Negishi, Tatsuya;
Ota, Hiroyoshi;
Umemura, Takeji

Publication type:

Article

Helicobacter pylori enhances HLA‐C expression in the human gastric adenocarcinoma cells AGS and can protect them from the cytotoxicity of natural killer cells.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13069

By:

Apoorva, Etikala;
Jacob, Rini;
Rao, Desirazu N.;
Kumar, Santosh

Publication type:

Article

Research progress in photodynamic therapy for Helicobacter pylori infection.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13068

By:

Luo, Qian;
Liu, Chunyan;
Zhang, Aiping;
Zhang, Dekui

Publication type:

Article

Oral immunotherapy for Helicobacter pylori: Can it be trusted? A systematic review.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13067

By:

Peypar, Mohammad Hossein;
Yeganeh, Amin Vesal;
Ramazani, Ali;
Alizadeh, Arman;
Abdorrashidi, Mahdi;
Tohidinia, Amirmohammad;
Shamlou, Mohammad Mahdi;
Heiat, Mohammad

Publication type:

Article

Antagonizing roles of SHP1 in the pathogenesis of Helicobacter pylori infection.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13066

By:

Chen, Si;
Zhao, Huilin;
Tian, Yue;
Wu, Qianwen;
Zhang, Jianhui;
Liu, Shuzhen;
Zhang, Ying;
Wu, Yulong;
Li, Boqing;
Chen, Shu;
Wang, Zhiqiang;
Xiao, Ruoyu;
Ji, Xiaofei

Publication type:

Article

Disruption of the gastric epithelial barrier in Correa's cascade: Clinical evidence via confocal endomicroscopy.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13065

By:

Wang, Shao‐Tong;
Yang, Hua‐Wei;
Zhang, Wen‐Lin;
Li, Zhen;
Ji, Rui

Publication type:

Article

Volatilomic signatures of different strains of Helicobacter pylori.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13064

By:

Vangravs, Reinis;
Mežmale, Linda;
Ślefarska‐Wolak, Daria;
Dauss, Edgars;
Ager, Clemens;
Corvalan, Alejandro H.;
Fernández, Elmer Andrés;
Mayhew, Chris A.;
Leja, Marcis;
Mochalski, Paweł

Publication type:

Article

Impact of mixed‐infection rate of clarithromycin‐susceptible and clarithromycin‐resistant Helicobacter pylori strains on the success rate of clarithromycin‐based eradication treatment.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13062

By:

Tsuda, Momoko;
Watanabe, Yoshiyuki;
Oikawa, Ritsuko;
Watanabe, Ryosuke;
Higashino, Masayuki;
Kubo, Kimitoshi;
Yamamoto, Hiroyuki;
Itoh, Fumio;
Kato, Mototsugu

Publication type:

Article

Refractoriness to anti‐Helicobacter pylori treatment attributed to phenotypic resistance patterns in patients with gastroduodenopathy in Guayaquil‐Ecuador.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13060

By:

Lara Icaza, Javier David;
Tapia, Rosalina Lara;
Triana, Cástula Tania Castro;
Ramírez, Laura Catalina Romero

Publication type:

Article

Meta‐analysis of Helicobacter pylori eradication therapy using vonoprazan as an acid suppressor compared with bismuth quadruple therapy.

Published in:

Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.13059

By:

Yang, Hui;
Zhang, Miao;
Ma, Gang;
Yang, Jiaqi;
Wang, Kemei;
Jiang, Shuangshuang;
Dong, Jiaqiang;
Han, Ying

Publication type:

Article

Issue Information.

Published in:: Helicobacter, 2024, v. 29, n. 2, p. 1, doi. 10.1111/hel.12992
Publication type:: Article